Curis
CRIS
#10260
Rank
โ‚น2.23 B
Marketcap
โ‚น55.95
Share price
-2.87%
Change (1 day)
-49.50%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): -โ‚น315.89

According to Curis's latest financial reports the company's current EPS (TTM) is -โ‚น342.70. In 2024 the company made an earnings per share (EPS) of -โ‚น656.46 an increase over its 2023 EPS that were of -โ‚น843.22.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น315.89-51.88%
2024-โ‚น656.46-22.15%
2023-โ‚น843.22-26.17%
2022-โ‚น1,14222.3%
2021-โ‚น933.80-25.37%
2020-โ‚น1,251-30.93%
2019-โ‚น1,812-2.02%
2018-โ‚น1,849
2016-โ‚น4,202-10%
2015-โ‚น4,669138.1%
2014-โ‚น1,96140%
2013-โ‚น1,401-25%
2012-โ‚น1,86866.67%
2011-โ‚น1,121

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น127.00-137.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น323.09-194.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น33.62-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น269.87-178.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น363.25 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-โ‚น1,050 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น131.67-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA